LYSOSEEKER
LIVE

Serial Number

79366202

Owner

Samsara Therapeutics

Attorney

Claudia W. Stangle

Filing Date

Jan 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LYSOSEEKER Trademark

Serial Number: 79366202 • Registration: 7470222

LYSOSEEKER is a trademark filed by Samsara Therapeutics on January 19, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Samsara Therapeutics (2 trademarks)

Afrikahaus, Große Reichenstraße 27

Entity Type: 03

Trademark Details

Filing Date

January 19, 2023

Registration Date

August 13, 2024

Published for Opposition

May 28, 2024

Goods & Services

Medical services, medical diagnostic testing services; medical and pharmaceutical consultancy; medical analysis services relating to the diagnosis and treatment of persons; laboratory analysis services relating to the diagnosis and treatment of persons in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases; medical examinations; medical screening; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases;medical analysis services relating to the treatment of patients for diagnosising and treating illnessnes

Scientific and technological research in the field of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, therapeutics, chemistry and biochemistry; Pharmaceutical products development; research and development of new products for others; pharmaceutical drug development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; database services, namely, electronic storage of data in computer databases; design, engineering, research, development and testing services in the field of pharmaceuticals, biotechnology, biology, biomedicine, genetics, molecular sciences, therapeutics, chemistry and biochemistry for medical, scientific, and technological applications; preparation of scientific analysis and evaluations namely, testing of pharmaceuticals and pharmaceutical product evaluation; consultancy relating to research and development in the field of therapeutics; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; development of pharmaceutical preparations and medicines; medical laboratory services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 18, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 25, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 4, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 30, 2023 REPR